RY 152.64 -0.722% TD 79.42 -0.3638% SHOP 86.76 0.2311% CNR 165.66 -0.2529% ENB 50.17 0.8645% CP 114.78 0.4463% BMO 119.46 0.395% TRI 223.44 -0.1118% CNQ 48.32 -1.2265% BN 63.27 -0.1263% ATD 82.05 -0.231% CSU 4214.73 0.4019% BNS 64.16 -1.1707% CM 68.67 0.0146% SU 52.85 -0.7139% TRP 56.41 2.0441% NGT 64.6 -0.9202% WCN 247.72 -0.394% MFC 35.62 -0.6138% BCE 45.62 -0.2405%

CanadaBis Capital Inc

Healthcare CA CANB

0.06CAD
-(-%)

Last update at 2024-07-19T16:58:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.100.35
LowHigh

Fundamentals

  • Previous Close 0.06
  • Market Cap34.56M
  • Volume28000
  • P/E Ratio8.33
  • Dividend Yield-%
  • EBITDA5.17M
  • Revenue TTM22.82M
  • Revenue Per Share TTM0.17
  • Gross Profit TTM 5.57M
  • Diluted EPS TTM0.03

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Income before tax 4.56M 0.61M -2.68091M -5.39108M -9.00286M
Minority interest 0.00000M 0.00038M 0.00414M 0.10M 0.10M
Net income 4.44M 0.61M -2.67677M -5.38878M -9.00286M
Selling general administrative 6.76M 4.23M 4.48M 5.60M 4.54M
Selling and marketing expenses - - - - -
Gross profit 11.78M 5.57M 2.52M 1.16M -0.04678M
Reconciled depreciation 0.67M 0.53M 0.47M 0.28M 0.06M
Ebit - 1.04M -2.28565M -4.72004M -4.64138M
Ebitda - 1.63M -1.81245M -4.78472M -8.92504M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 4.68M 1.04M -2.28565M -4.72004M -4.64138M
Other operating expenses - - - - -
Interest expense 0.45M 0.49M 0.40M 0.32M 0.02M
Tax provision 0.12M 0.00000M - - -
Interest income - - - - -
Net interest income -0.44611M -0.49263M -0.39954M -0.67637M -0.01915M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 22.22M 11.67M 6.87M 4.43M 0.00000M
Total operating expenses 17.55M 10.63M 9.15M 9.15M 4.64M
Cost of revenue 10.44M 6.10M 4.35M 3.27M 0.05M
Total other income expense net 0.33M 0.06M 0.00428M 0.00533M -4.34233M
Discontinued operations - - - - -
Net income from continuing ops 4.44M 0.61M -2.68091M -5.39108M -9.00286M
Net income applicable to common shares - 0.61M -2.67677M -5.38878M -9.00286M
Preferred stock and other adjustments - - - - -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Total assets 22.96M 15.48M 13.28M 12.52M 5.36M
Intangible assets - - 0.00771M 0.02M -
Earning assets - - - - -
Other current assets - 0.06M 0.03M 0.07M 0.03M
Total liab 15.62M 12.84M 11.46M 9.09M 2.51M
Total stockholder equity 7.25M 2.54M 1.73M 3.34M 2.85M
Deferred long term liab - - - - -
Other current liab - 0.77M 0.70M 0.59M 0.38M
Common stock - 16.15M 16.00M 15.39M 10.57M
Capital stock 16.73M 16.15M 16.00M 15.39M 10.57M
Retained earnings -12.46811M -16.91260M -17.52094M -14.84416M -9.45538M
Other liab - 0.04M 0.06M - -
Good will - - - - -
Other assets - 0.29M 0.29M 0.00643M 0.23M
Cash 3.23M 0.14M 0.85M 0.17M 0.32M
Cash and equivalents - - - - -
Total current liabilities 9.68M 11.90M 10.14M 7.73M 1.36M
Current deferred revenue - - - - -
Net debt 2.75M 7.08M 6.59M 5.49M 1.57M
Short term debt - - - - 0.75M
Short long term debt 1.01M 6.75M 6.99M 4.69M 0.75M
Short long term debt total - - - - -
Other stockholder equity - 3.31M 3.25M 2.80M 1.74M
Property plant equipment - 9.51M 10.09M 9.77M 4.12M
Total current assets 11.63M 5.68M 2.90M 2.73M 1.02M
Long term investments - - - - -
Net tangible assets - 2.54M 1.72M 3.32M 2.85M
Short term investments - - - - 0.40M
Net receivables 1.81M 2.14M 0.67M 1.31M 0.08M
Long term debt 4.97M 0.47M 0.46M 0.96M 1.14M
Inventory 5.83M 2.93M 1.22M 1.08M 0.09M
Accounts payable 6.43M 3.54M 1.33M 1.79M 0.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 4.34M
Deferred long term asset charges - - - - -
Non current assets total 11.33M 9.80M 10.38M 9.79M 4.34M
Capital lease obligations 1.33M 0.59M 1.00M 0.40M -
Long term debt total - - - - -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Investments -0.96582M -0.20977M 0.12M -2.38753M -1.95027M
Change to liabilities - 2.19M -0.61421M 0.84M 0.00076M
Total cashflows from investing activities - -0.20977M 0.12M -2.38753M -1.95027M
Net borrowings - -1.02849M 2.05M 4.54M -0.35731M
Total cash from financing activities -1.50170M -0.41209M 2.37M 5.85M 3.29M
Change to operating activities - -0.25120M 0.20M -0.14202M -0.52257M
Net income 4.44M 0.61M -2.67677M -5.38878M -9.00286M
Change in cash 3.08M -0.70463M 0.68M -0.15780M -0.35415M
Begin period cash flow 0.14M 0.85M 0.17M 0.32M 0.68M
End period cash flow 3.23M 0.14M 0.85M 0.17M 0.32M
Total cash from operating activities 5.55M -0.08277M -1.80666M -3.61932M -1.69470M
Issuance of capital stock 0.21M 0.15M 0.54M 1.28M 3.65M
Depreciation 0.67M 0.53M 0.47M 0.28M 0.06M
Other cashflows from investing activities - - 0.27M 0.58M 0.21M
Dividends paid 0.00000M 0.00000M - - -
Change to inventory -2.97840M -1.81286M -0.16640M -1.24076M -1.24076M
Change to account receivables 0.14M -1.46644M 0.40M -1.07234M -1.07234M
Sale purchase of stock - - - - -
Other cashflows from financing activities - -0.00105M -0.22500M 0.03M 0.03M
Change to netincome - 0.12M 0.58M 3.10M 7.77M
Capital expenditures 0.98M 0.21M 0.15M 4.96M 2.63M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.09M -1.33798M -0.15777M -0.95133M -0.67977M
Stock based compensation 0.05M 0.05M 0.46M 2.69M 3.33M
Other non cash items 0.13M 0.04M -0.02510M -0.24793M 4.59M
Free cash flow 4.57M -0.29254M -1.95899M -8.58483M -4.32828M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CANB
CanadaBis Capital Inc
- -% 0.06 8.33 - 1.51 4.30 1.69 6.60
RX
Biosyent Inc.
0.05 0.50% 10.05 16.47 16.26 3.21 2.88 2.32 8.03
LOVE
Cannara Biotech Inc
-0.06 9.09% 0.60 10.00 - 1.26 0.90 1.98 7.20
DB
Decibel Cannabis Company Inc
0.005 8.33% 0.07 - 3.38 0.48 1.17 0.87 39.48
LSL
LSL Pharma Group Inc.
- -% 0.49 - - 4.65 4.23 6.13 -14.2493

Reports Covered

Stock Research & News

Profile

CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through three segments: Cultivation and Wholesale, Retail, and Extract. The Cultivation and Wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. The Retail segment sells cannabis and cannabis related products to end consumers on premise owned and operated by the company. The Extract segment provides cannabinoid extraction services to other licensed producers. CanadaBis Capital Inc. is based in Red Deer County, Canada.

CanadaBis Capital Inc

255C Clearview Drive, Red Deer, AB, Canada, T4E 3B6

Key Executives

Name Title Year Born
Mr. Travis Gerald McIntyre Pres, CEO & Director 1981
Mr. Shane Chana C.A., CPA CFO & Director 1986
Ms. Barbara O'Neill Corp. Sec. & Director 1967

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.